July 13, 2018

July 13, 2018

Moffitt licensing deal could provide new approach for some cancer patients

Tampa Bay Business Journal – July 11

Moffitt Cancer Center and MultiVir Inc., a Houston-based immune oncology company, have agreed to work together to develop a personalized cancer vaccine.

FDA Approves Immunotherapy Combination for Metastatic Colorectal Cancer

Cure Magazine – July 11

“For patients with dMMR/MSI-H (metastatic) CRC, the FDA approval of combination ipilimumab and nivolumab provides a novel therapeutic option with a higher response rate than that from monotherapy immunotherapy. It is encouraging that durable disease control and promising survival is also seen,” Aaron Franke, M.D., MSc, hematology/oncology fellow at the Moffitt Cancer Center, said in an interview with CURE. 

Ronald A. Christaldi selected by Business Journals as One of Nation’s 100 Most Influential Attorneys

Tampa Bay Newswire – July 11

Joining Ron on the list is his longtime mentor, Moffitt Cancer Center General Counsel, L. David de la Parte.  Ron credits David for his success, “Without question, I would not be the professional that I am today without David’s years of mentoring, guidance and wisdom.  He is, hands down, the best lawyer and most talented business individual I have worked with.”

Extended Tamoxifen May Double Endometrial Cancer Risk

MedPage Today – July 10

These data would not preclude the use of extended tamoxifen in women who are deemed appropriate, Hatem Soliman, MD, of H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, told MedPage Today. 

Medical marijuana regulators withdraw licensing fee rule

FloridaPolitics.com – July 10

The money from the fee would help fund the Coalition for Medical Marijuana Research and Education within the H. Lee Moffitt Cancer Center and Research Institute in Tampa.

Komrokji Reveals Therapeutic Strategies for Patients with AML

Targeted Oncology – July 10

 Komrokji, professor of oncologic sciences, University of South Florida, and vice chair of the Department of Hematologic Malignancies, Moffitt Cancer Center, explained his treatment decisions based on 2 case scenarios during a Targeted Oncology live case-based peer perspectives presentation.

An Overview of Myeloproliferative Neoplasms

OncLive – July 10

Participating today on our distinguished panel are Dr. Rami Komrokji, senior member and professor of Oncologic Sciences, section head for Leukemia and Myelodysplastic Syndrome, and vice chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida; …

3-D mural inspires Moffitt patients battling cancer

Bay News 9 – July 9

A one-of-a-kind mural at Moffitt Cancer Center is guiding patients through their treatment process and easing the anxiety of the often life-changing diagnosis.

Meet Our 2018 Research Grantees: Early Career Awards

Pancreatic Cancer Action Network – July 9

The final 2018 young investigator grant was awarded to Karen Mann, PhD, an assistant member in the department of molecular oncology at Moffitt Cancer Center in Tampa, Fla. Mann received a Career Development Award, providing $200,000 over two years. Her grant was also funded in memory of Skip Viragh.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.